You can buy or sell ADIL and other stocks, options, ETFs, and crypto commission-free!
Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. Read More The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA. The listed name for ADIL is Adial Pharmaceuticals, Inc Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 12, After Hours